Berman Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $1.29M | Buy |
2,266
+477
| +27% | +$272K | 0.2% | 61 |
|
|
2021
Q2 | $901K | Buy |
1,789
+264
| +17% | +$133K | 0.14% | 72 |
|
|
2021
Q1 | $695K | Buy |
1,525
+211
| +16% | +$96.2K | 0.15% | 71 |
|
|
2020
Q4 | $611K | Buy |
1,314
+83
| +7% | +$38.6K | 0.15% | 75 |
|
|
2020
Q3 | $543K | Sell |
1,231
-3
| -0.2% | -$1.32K | 0.15% | 70 |
|
|
2020
Q2 | $446K | Buy |
1,234
+201
| +19% | +$72.6K | 0.12% | 74 |
|
|
2020
Q1 | $292K | Buy |
1,033
+248
| +32% | +$70.1K | 0.09% | 87 |
|
|
2019
Q4 | $254K | Buy |
785
+20
| +3% | +$6.47K | 0.07% | 117 |
|
|
2019
Q3 | $222K | Buy |
765
+28
| +4% | +$8.13K | 0.07% | 118 |
|
|
2019
Q2 | $216K | Buy |
737
+67
| +10% | +$19.6K | 0.07% | 125 |
|
|
2019
Q1 | $183K | Buy |
670
+130
| +24% | +$35.5K | 0.06% | 132 |
|
|
2018
Q4 | $120K | Buy |
+540
| New | +$120K | 0.05% | 154 |
|